Rainmed Medical Limited (2297.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
Sector
Healthcare
Industry
Medical - Devices
Employees
270
First IPO Date
July 08, 2022
| Name | Title | Pay | Year Born |
| Yonghui Lyu | Chief Executive Officer | 1.83M | 1977 |
| Zeke Zhu | Joint Chief Executive Officer & Executive Director | 1.97M | 1985 |
| Jing Duan | Director for HR Department & Executive Director | 615,800 | 1985 |
| Yunfei Huo | Executive Chairman of the Board | 1.26M | 1979 |
| Liang Zhang | Joint Company Secretary | 1.96M | 1982 |
| Cheuk Ting Chu | Joint Company Secretary | 1.96M | 1980 |
| Kangjian Liu | Vice President & Board Secretary | 0 | N/A |
| Nina Cheng | International Marketing Manager | 0 | N/A |
| Chang Zhou | Vice President | 0 | 1978 |
| Xingyun Wu | Vice President | 0 | 1977 |
| Guangzhi Liu | Chief Technology Officer | 0 | 1981 |
Rainmed Medical Limited is a medical technology firm specializing in the creation, development, and market launch of advanced systems that utilize coronary angiography to assess fractional flow reserve (FFR) and the index of microvascular resistance (IMR). Its offerings include the FlashAngio caFFR System, which accurately determines FFR values by reconstructing a three-dimensional model of the coronary arterial system from two angiographic images. Additionally, the company provides the FlashAngio caIMR System, an innovative non-invasive solution for the diagnosis and treatment of microcirculatory lesions. Rainmed Medical is also engaged in pioneering intelligent angiographic injection technologies, robotic navigation systems for vascular interventions, and flash renal denervation solutions. Established in 2014, the company is headquartered in Suzhou, China.